Talk:Somatostatin

From Wikipedia, the free encyclopedia

WikiProject Medicine This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess.
Start This page has been rated as Start-Class on the quality assessment scale
Low This article has been rated as Low-importance on the importance assessment scale
Molecular and Cellular Biology WikiProject This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme.

Article Grading: The article has not been rated for quality and/or importance yet. Please rate the article and then leave comments here to explain the ratings and/or to identify the strengths and weaknesses of the article. Click here for an overview of how to rate this article.

[edit] in-Merger of "Octreotide"

I've taken the "Octreotide" article and brought it into this one. I did this for two reasons. First, as a method for clearing a Template:bio-stub. Second, and more importantly, because it provides an immediate context for the drug; as it mimics somatostatin, having it in the context of somatostatin makes sense to me. If you (other editors) do not agree with this, I would ask that you not separate the two concepts unless you are going to add substantially more information to the "Octreotide" article so that it can stand as a non-stub article. Regards, Courtland 01:10, 2005 Mar 12 (UTC) (also repeated on the Octretide talk page)

[edit] No mention of Lanreotide

I would advise adding a section about Lanreotide http://www.dundee.ac.uk/medther/tayendoweb/lanreotide.htm